🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a double-blind, individually randomised trial, to assess the s...
Status
Active Not Recruiting
Location
Koumantou Study Clinic
Start Date
2025-03-19
Trial ID
NCT06080243
Treatments Being Tested
This is a randomized, observer-blinded, Phase 1/2 study with an open-label ...
Status
Withdrawn
Location
Australian Clinical Research Network (ACRN)
Start Date
2022-02-04
Trial ID
NCT05029856
Treatments Being Tested
This is a clinical trial in which healthy volunteers will be administered o...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Start Date
2015-10-15
Trial ID
NCT02572388
The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-10
Trial ID
NCT07779408
This is a study to evaluate the efficacy, immune response, and safety of a ...
Status
Completed
Location
Belfast Health and Social Care Trust (BHSCT) (Site UK011)
Start Date
2020-09-28
Trial ID
NCT04583995
Treatments Being Tested
A phase 1/2, open-label clinical trial in individuals, 18 years of age and ...
Status
Completed
Location
The Hope Clinic of Emory University
Start Date
2021-05-28
Trial ID
NCT04889209
Treatments Being Tested
This study is a Phase 3 trial designed to check the safety and immune respo...
Status
Completed
Location
Investigational Site Number US404
Start Date
2025-10-09
Trial ID
NCT07079670
Treatments Being Tested
This is a randomized, double-blind, factorial study to compare the reductio...
Status
Completed
Location
University of Alabama Vaccine Research Unit
Start Date
2014-07
Trial ID
NCT02114060
This is a voluntary study to allow subjects who received placebo while on G...
Status
Completed
Location
University of Alabama Vaccine Research Unit
Start Date
2015-01
Trial ID
NCT02300142
This is an open-label Phase 3 study evaluating the immunogenicity and safet...
Status
Completed
Location
Benchmark Research
Start Date
2023-03-28
Trial ID
NCT05875701
Treatments Being Tested